Hemagglutinin and neuraminidase genes of influenza B viruses circulating in Riyadh, Saudi Arabia during 2010-2011: Evolution and sequence analysis

Journal of Medical Virology

Volumn 86, Issue 6, 2014, Pages 1003-1016

  Ali, Ghazanfar ^a,d   Amer, Haitham M ^b,c   Almajhdi, Fahad N ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c Cairo University   (Egypt)

^d UNIVERSITY OF AZAD JAMMU AND KASHMIR   (Pakistan)

Author keywords

DNA sequencing; Hemagglutinin; Influenza B virus; Neuraminidase; Phylogenetic analysis; Saudi Arabia

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; SIALIDASE; VIRUS RNA; INFLUENZA VIRUS HEMAGGLUTININ; NA PROTEIN, INFLUENZA B VIRUS; VIRUS PROTEIN;

ARTICLE; DNA SEQUENCE; EVOLUTION; GENE AMPLIFICATION; HEMAGGLUTININ GENE; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS B; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SAUDI ARABIA; SEQUENCE ANALYSIS; SIALIDASE GENE; SPECIES COMPARISON; SPECIES DISTRIBUTION; STRAIN DIFFERENCE; STRAIN IDENTIFICATION; UNINDEXED SEQUENCE; VIRAL GENETICS; VIRUS DETECTION; VIRUS GENE; VIRUS STRAIN; AMINO ACID SUBSTITUTION; CLASSIFICATION; EPIDEMIOLOGY; GENETIC VARIABILITY; GENETICS; GENOTYPE; HOSPITALIZATION; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MOLECULAR EPIDEMIOLOGY; MOLECULAR GENETICS; NASOPHARYNX; VIROLOGY;

INFLUENZA B VIRUS; ORTHOMYXOVIRIDAE;

AMINO ACID SUBSTITUTION; GENETIC VARIATION; GENOTYPE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HOSPITALIZATION; HUMANS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; NASOPHARYNX; NEURAMINIDASE; PHYLOGENY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SAUDI ARABIA; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS;

EID: 84897962600     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23819     Document Type: Article

References (50)

1. Air GM, Gibbs AJ, Laver WG, Webster RG. 1990. Evolutionary changes in influenza B are not primarily governed by antibody selection. Proc Natl Acad Sci USA 87:3884-3888.
2. Almajhdi FN. 2010. The identification of the first isolate of influenza B virus using a duplex RT-PCR DNA sequencing in Saudi Arabia (B/Riyadh/01/2007). Afr J Microbiol Res 4:697-703.
3. Al-Shehri MA, Sadeq A, Quli K. 2005. Bronchiolitis in Abha, Southwest Saudi Arabia: viral etiology and predictors for hospital admission. West Afr J Med 24:299-304.
4. Bakir TM, Halawani M, Ramia S. 1998. Viral aetiology and epidemiology of acute respiratory infections in hospitalized Saudi children. J Trop Pediatr 44:100-103.
5. Berton MT, Webster RG. 1985. The antigenic structure of the influenza B virus hemagglutinin: operational and topological mapping with monoclonal antibodies. Virology 143:583-594.
6. Berton MT, Naeve CW, Webster RG. 1984. Antigenic structure of the influenza B virus hemagglutinin: Nucleotide sequence analysis of antigenic variants selected with monoclonal antibodies. J Virol 52:919-927.
7. Chen R, Holmes EC. 2008. The evolutionary dynamics of human influenza B virus. J Mol Evol 66:655-663.
8. Chen GW, Shih SR, Hsiao MR, Chang SC, Lin SH, Sun CF, Tsao KC. 2007. Multiple genotypes of influenza B viruses cocirculated in Taiwan in 2004 and 2005. J Clin Microbiol 45:1515-1522.
9. Chen Z, Aspelund A, Jin H. 2008. Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs. Vaccine 26:361-371.
10. Chi XS, Hu A, Bolar TV, Al-Rimawi W, Zhao P, Tam JS, Rappaport R, Cheng SM. 2005. Detection and characterization of new influenza B virus variants in 2002. J Clin Microbiol 43:2345-2349.
11. Daum LT, Canas LC, Klimov AI, Shaw MW, Gibbons RV, Shrestha SK, Myint KS, Acharya RP, Rimal N, Reese F, Niemeyer DM, Arulanandam BP, Chambers JP. 2006. Molecular analysis of isolates from influenza B outbreaks in the U.S. and Nepal, 2005. Arch Virol 151:1863-1874.
12. Gröndahl B, Puppe W, Hoppe A, Kühne I, Weigl JA, Schmitt HJ. 1999. Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: Feasibility study. J Clin Microbiol 37:1-7.
13. Hatakeyama S, Sugaya N, Ito M, Yamazaki M, Ichikawa M, Kimura K, Kiso M, Shimizu H, Kawakami C, Koike K, Mitamura K, Kawaoka Y. 2007. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. J Am Med Assoc 297:1435-1442.
14. Hay AJ, Gregory V, Douglas AR, Lin YP. 2001. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 356:1861-1870.
15. Kanegae Y, Sugita S, Endo A, Ishida M, Senya S, Osako K, Nerome K, Oya A. 1990. Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: Cocirculating lineages in the same epidemic season. J Virol 64:2860-2865.
16. Krystal M, Elliott RM, Benz EW Jr, Young JF, Palese P. 1982. Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proc Natl Acad Sci USA 79:4800-4804.
17. Lamb RA, Choppin PW. 1983. The gene structure and replication of influenza virus. Ann Rev Biochem 52:467-506.
18. Lin JH, Chiu SC, Shaw MW, Lin YC, Lee CH, Chen HY, Klimov A. 2007. Characterization of the epidemic influenza B viruses isolated during2004-2005 season in Taiwan. Virus Res 124:204-211.
19. Lugovtsev VY, Vodeiko GM, Strupczewski CM, Ye Z, Levandowski RA. 2007. Generation of the influenza B viruses with improved growth phenotype by substitution of specific amino acids of hemagglutinin. Virology 365:315-323.
20. McCullers JA, Saito T, Iverson AR. 2004. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol 78:12817-12828.
21. McCullers JA, Wang GC, He S, Webster RG. 1999. Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature. J Virol 73:7343-7348.
22. Motta FC, Siqueira MM, Lugon AK, Straliotto SM, Fernandes SB, Krawczuk MM. 2006. The reappearance of Victoria lineage influenza B virus in Brazil, antigenic and molecular analysis. J Clin Virol 36:208-214.
23. Nakagawa N, Kubota R, Nakagawa T, Okuno Y. 2001. Antigenic variants with amino acid deletions clarify a neutralizing epitope specific for influenza B virus Victoria group strains. J Gen Virol 82:2169-2172.
24. Nakagawa N, Kubota R, Nakagawa T, Okuno Y. 2003. Neutralizing epitopes specific for influenza B virus Yamagata group strains are in the 'loop'. J Gen Virol 84:769-773.
25. Nakagawa N, Kubota R, Okuno Y. 2005. Variation of the conserved neutralizing epitope in influenza B virus victoria group isolates in Japan. J Clin Microbiol 43:4212-4214.
26. Nerome R, Hiromoto Y, Sugita S, Tanabe N, Ishida M, Matsumoto M, Lindstrom SE, Takahashi T, Nerome K. 1998. Evolutionary characteristics of influenza B virus since its first isolation in 1940: Dynamic circulation of deletion and insertion mechanism. Arch Virol 143:1569-1583.
27. Osterhaus AD, Rimmelzwaan GF, Martina BE, Bestebroer TM, Fouchier RA. 2000. Influenza B virus in seals. Science 288:1051-1053.
28. Rashid H, Shafi S, Haworth E, El Bashir H, Memish ZA, Sudhanva M, Smith M, Auburn H, Booy R. 2008. Viral respiratory infections at the Hajj: Comparison between UK and Saudi pilgrims. Clin Microbiol Infect 14:569-574.
29. Roberts PC, Garten W, Klenk HD. 1993. Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin. J Virology 67:3048-3060.
30. Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K. 1990. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 175:59-68.
31. Rota PA, Hemphill ML, Whistler T, Regnery HL, Kendal AP. 1992. Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus. J Gen Virol 73:2737-2742.
32. Roy T, Agrawal AS, Mukherjee A, Mishra AC, Chadha MS, Kaur H, Chawla-Sarkar M. 2011. Surveillance and molecular characterization of human influenza B viruses during 2006-2010 revealed co-circulation of Yamagata-like and Victoria-like strains in eastern India. Infect Genet Evol 11:1595-1601.
33. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ. 2008. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 26:D31-D34.
34. Saito T, Nakaya Y, Suzuki T, Ito R, Saito H, Takao S, Sahara K, Odagiri T, Murata T, Usui T, Suzuki Y, Tashiro M. 2004. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation. J Med Virol 74:336-343.
35. Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406-425.
36. Shaw MW, Lamb RA, Erickson BW, Briedis DJ, Choppin PW. 1982. Complete nucleotide sequence of the neuraminidase gene of influenza B virus. Proc Natl Acad Sci USA 79:6817-6821.
37. Shaw MW, Xu X, Li Y, Normand S, Ueki RT, Kunimoto GY, Hall H, Klimov A, Cox NJ, Subbarao K. 2002. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology 303:1-8.
38. Shen J, Kirk BD, Ma J, Wang Q. 2009. Diversifying selective pressure on influenza B virus hemagglutinin. J Med Virol 81:114-124.
39. Shibata S, Yamamoto-Goshima F, Maeno K, Hanaichi T, Fujita Y, Nakajima K, Imai M, Komatsu T, Sugiura S. 1993. Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase. J Virol 67:3264-3273.
40. Skehel JJ, Wiley DC. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531-569.
41. Sun S, Wang Q, Zhao F, Chen W, Li Z. 2011. Glycosylation site alteration in the evolution of influenza A (H1N1) viruses. PLoS ONE 6:e22844.
42. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. 2004. Influenza-associated hospitalizations in the United States. J Am Med Assoc 292:1333-1340.
43. Treanor J. 2004. Influenza vaccine-Outmaneuvering antigenic shift and drift. New Engl J Med 350:218-220.
44. Tsai HP, Wang HC, Kiang D, Huang SW, Kuo PH, Liu CC, Su IJ, Wang JR. 2006. Increasing appearance of reassortant influenza B virus in Taiwan from 2002 to 2005. J Clin Microbiol 44:2705-2713.
45. Wang Q, Cheng F, Lu M, Tian X, Ma J. 2008. Crystal structure of unliganded influenza B virus hemagglutinin. J Virol 82:3011-3020.
46. WHO. 2003. Recommended composition of influenza virus vaccines for use in the 2003-2004 in fluenza season, Weekly Epidemiological Records pp: 58-62.
47. Wiley DC, Wilson IA, Skehel JJ. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373-378.
48. Xu X, Lindstrom SE, Shaw MW, Smith CB, Hall HE, Mungall BA, Subbarao K, Cox NJ, Klimov A. 2004. Reassortment and evolution of current human influenza A and B viruses. Virus Res 103:55-60.
49. Yang JR, Huang YP, Chang FY, Hsu LC, Lin YC, Huang HY, Wu FT, Wu HS, Liu MT. 2012. Phylogenetic and evolutionary history of influenza B viruses, which caused a large epidemic in 2011-2012, Taiwan. PLoS ONE 7:e47179.
50. Zaman RU, Alamgir AS, Rahman M, Azziz-Baumgartner E, Gurley ES, Sharker MA, Brooks WA, Azim T, Fry AM, Lindstrom S, Gubareva LV, Xu X, Garten RJ, Hossain MJ, Khan SU, Faruque LI, Ameer SS, Klimov AI, Luby SP. 2009. Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007-2008. PLoS ONE 4:e8452.